Treetop Meeting

27/08/2025

We usually do not share updates from internal meetings – but this was too fantastic not to share. A full day meeting in the midst of branches of +100 year old oaks and beech trees overlooking Isefjorden in “the treetop huts” at Ryegaard & Trudsholm Godser....

The 10 Advisements

01/07/2025

We have the utmost respect for the courage, dedication, and resilience it takes to be an entrepreneur in our industry – especially when you’re out raising your next round of financing. That’s why we’ve decided to share our “10 Advisements” for crafting a...

Neumirna Therapeutics secures euro 20M in Series A financing

08/01/2025

Neumirna Therapeutics secures euro 20M in Series A financing Neumirna Therapeutics (‘Neumirna’), an RNA-focused biotech company developing next-generation therapeutics for neurological disorders, is pleased to announce the first closing of its Series A funding round...

Saving Lives with Venture Capital

07/09/2024

In 2023 we posted our thoughts on how to calculate the potential lifesaving impact of biotech venture capital (https://bit.ly/3z4mL0o) – and we promised to expand on the topic. Unfortunately, or rather fortunately, we got busy making investments in DioGenX, Kynexis...

The VC summer dream – the Fund Returner

08/07/2024

The VC summer dream – the Fund ReturnerSunstone has over the past years continuously highlighted observations and learnings from successes in European biotech. The learnings have consolidated, tuned and verified our current investment strategy. Sunstone is today...